Silvers Daniel B. 13D and 13G filings for Ensysce Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-07-07 09:08 am Unchanged | 2022-06-30 | 13D | Ensysce Biosciences, Inc. ENSC | Silvers Daniel B. | 801 7.900% | 0 (Unchanged) | Filing |
2021-10-12 4:15 pm Unchanged | 2021-10-07 | 13D | Ensysce Biosciences, Inc. ENSC | Silvers Daniel B. | 801 11.080% | 0 (Unchanged) | Filing |
2021-07-06 4:15 pm Purchase | 2021-06-30 | 13D | Ensysce Biosciences, Inc. ENSC | Silvers Daniel B. | 801 11.080% | 801![]() (New Position) | Filing |